Curriculum Vitae
KEVIN NOLAN MORRIS, PH.D.
PERSONAL
Nationality: United States of America
Mailing Address: 1288 South Corona Street, Denver, Colorado 80210
Phone: 303-564-3886
Email: kevin.n.morris@gmail.com
EDUCATION
Ph.D., Biochemistry and Molecular Biology, 1991
University of Chicago
Chicago, Illinois
B.A., Molecular Biology, 1986
University of California
Berkeley, California
PROFESSIONAL POSITIONS
Scientific Consultant
Morris Consulting
Denver, Colorado
September 2012 to Present
(Clients include American Humane Association, Washington, DC; University of Denver,
Institute for Human-Animal Connection, Denver, Colorado; Parsemus Foundation,
Berkeley, California; Coalition for Living Safely with Dogs, Denver, Colorado)
Director of Research
Animal Assistance Foundation
Denver, Colorado
August 2008 to August 2012
Founding Partner
Sirius Medicine, LLC
Loveland, Colorado
June 1998 to July 2008
Scientific Consultant
SomaLogic, Inc.
Boulder, Colorado
1999
Kevin Nolan Morris, Ph.D.
1
Scientific Consultant
Division of Tumor Biology and Imaging
NeXstar Pharmaceuticals, Inc.
Boulder, Colorado
1994 to 1998
Guest Lecturer
Department of Genetics
University of Salzburg
Salzburg, Austria
1997 to 1998
Guest Professor
Austrian Academy of Science
Institute of Molecular Biology
Salzburg, Austria
1995 to 1998
Ruth Saks Fellow
Cancer Research Fund of the Damon Runyon-Walter Winchell Foundation
Department of Molecular, Cellular and Developmental Biology
University of Colorado
Boulder, Colorado
1991 to 1994
Doctoral Student
Department of Biochemistry and Molecular Biology
University of Chicago
Chicago, Illinois
1987 to 1991
Research Associate
Department of Biochemistry and Molecular Biology
University of California
Irvine, California
1986 to 1987
Undergraduate Research Associate
Department of Molecular Biology
University of California
Berkeley, California
1985 to 1986
Kevin Nolan Morris, Ph.D.
2
VOLUNTEER POSITIONS
Board of Directors, Treasurer
Alliance for Contraception in Cats and Dogs (ACC&D)
Portland, Oregon
2011 to Present
Scientific Advisor
Savio
Denver, Colorado
2009 to Present
Scientific Advisor
Coalition for Living Safely with Dogs
Denver, Colorado
2008 to Present
President
Homer Allied Research Project (HARP)
Denver, Colorado
2001 to 2007
Volunteer
Max Fund Animal Shelter
Denver, Colorado
1999 to 2005
GRANTS
Human Animal Bond Research Initiative (HABRI) Grant
The Canines and Childhood Cancer Study: Examining behaviors and stress in
therapy dogs
Co-Principal Investigator
American Humane Association
$30,000
2013
Animal Assistance Foundation Grant
Trends in Colorado animal shelter intake and outcome data: A 5-year follow-up study.
Principal investigator
American Humane Association
$2,500
2013
Ruth Saks Fellowship
Cancer Research Fund of the Damon Runyon-Walter Winchell Foundation
Kevin Nolan Morris, Ph.D.
3
The role of RNA in the early biosphere.
University of Colorado, Boulder
$75,000
1991 to 1994
PUBLICATIONS
Morris, K.N. and Olson, P. (2014) Trends in intake and outcome data for animal shelters
in Colorado, 2000 – 2012 – A five-year update. In preparation.
Morris, K.N. and Gies, D.L. (2014) Trends in intake and outcome data for animal shelters
in a large U.S. metropolitan area, 1989 to 2010. Journal of Applied Animal Welfare
Science, 17, 59-72.
Morris, K.N., Wolf, J.L. and Gies, D.L. (2011) Trends in intake and outcome data for
animal shelters in Colorado, 2000 to 2007. Journal of the American Veterinary Medical
Association, 238, 329-336.
Morris, K.N., Weil, M.D. and Malzbender, R. (2006) Radiochromic film dosimetry of
contrast-enhanced radiotherapy (CERT). Physics in Medicine and Biology, 51, 59155925.
Morris, K.N., Jensen, K.B., Julin, C.M., Weil, M.D., and Gold, L. (1998) High affinity
ligands from in vitro selection: Complex targets. Proceedings of the National Academy of
Science, USA, 95, 2902-2907.
Morris, K.N., Tarasow, T.M., Julin, C.M., Simons, S.L., Hilvert, D., and Gold, L. (1994)
Enrichment for RNA molecules that bind a Diels-Alder transition state analog.
Proceedings of the National Academy of Science, USA, 91, 13028-13032.
Morris, K.N., and Wool, I.G. (1994) Analysis of the contribution of an amphiphilic helix to the structure and function of ricin A chain. Proceedings of the National Academy
of Science, USA, 91, 7530-7533.
Morris, K.N., and Wool, I.G. (1992) Determination by systematic deletion of amino acids
essential for catalysis by ricin A chain. Proceedings of the National Academy of Science,
USA, 89, 4869-4873.
CONFERENCE ORAL PRESENTATIONS
Morris, K., McCullough, A., Jenkins, M. and Ruehrdanz, A. (July 25-29, 2014) The
Canines and Childhood Cancer (CCC) Study: An Evidence-Based Approach to
Researching Animal-Assisted Therapy and Its Effects on Therapy Dogs in Pediatric
Oncology Settings. AVMA Convention: Denver, Colorado.
Kevin Nolan Morris, Ph.D.
4
Morris, K. (April 22-25, 2014) Dog bites in Colorado July 2007-June 2010: Data,
conclusions and tips for keeping communities safer. Rocky Mountain regional
Animal Control Conference and Training: Golden, Colorado.
Morris, K.N. (September 12-13, 2013) Colorado cat sheltering dynamics. American
Humane Association Cat Health and Welfare Forum: Orlando, Florida.
McCullough, A. and Morris, K. (July 19-23, 2013). The Canines and Childhood
Cancer Study: Examining the physiological impacts of human-animal interactions for
children with acute lymphoblastic leukemia, their parents/caregivers, and therapy
dogs. International Association of Human-Animal Interaction Organizations’
Triennial Conference: Chicago, Illinois.
Morris, K., McCullough, A., Roguski, J. and Bishop, A. (July 18-19, 2013).
Measuring the efficacy of an animal-assisted therapy protocol within a family
preservation and reunification program – The Savio Study. International Society for
Anthrozoology Conference: Chicago, Illinois.
Morris, K., McCullough, A. and Jenkins, M. (March 14-17, 2013). Canines and
Childhood Cancer: Examining the impacts of animal-assisted therapy on pediatric
oncology patients, their families, and participating therapy dogs. American Animal
Hospital Association Conference: Phoenix, Arizona.
Morris, K. and Gies, D. (May 4-7, 2011). The collection, analysis and use of shelter
intake and outcome statistics. The Humane Society of the United States 20th Annual
Animal Care Expo: Orlando, Florida.
Morris, K. (April 6-8, 2011). Trends for animal shelters with mandated reporting.
American Humane Association – Mars Animal Wellbeing Consortium – Phase I:
Englewood, Colorado.
Morris, K. (May 15, 2010). Trends in Colorado and metro Denver shelter statistics.
2010 Spay Colorado Day: Englewood, Colorado.
Gies, D. and Morris, K. (October 20-25, 2009) Development of a sustainable funding
strategy for AAT and HAI in Colorado. International Society for Anthrozoology, 18th
Annual Conference: Kansas City, Missouri.
Morris, K.N., Weil, M.D. and Malzbender, R. (2004). Phantom dosimetry of contrastenhanced radiotherapy (CERT). Annual Meeting of the American Association of
Physicists in Medicine: Pittsburgh, Pennsylvania.
Morris, K.N., Lewis, D.F., Listl, C.A., Weil, M.D. (2003). Radiochromic film dosimetry
of radiation dose enhancement by diagnostic contrast agents. Annual Meeting of the
American Association of Physicists in Medicine: San Diego, California.
Kevin Nolan Morris, Ph.D.
5
Morris, K.N. (1998). Antagonists as cancer vaccine adjuvants – Curing incurable cancer.
Sirius Medicine Conference: Telluride, Colorado.
Morris, K.N., Tarasow, T.M., Julin, C.M., Simons, S.L., Hilvert, D., and Gold, L. (1994).
Enrichment for RNA molecules that bind a Diels-Alder transition state analog. 85th
Annual Meeting of the American Society for Biochemistry and Molecular Biology:
Washington, D.C.
Morris, K.N. and Wool, I.G. (1994). Analysis of the contribution of an amphiphilic helix to the structure and function of ricin A chain. Third International Symposium on
Immunotoxins: Lake Buena Vista, Florida.
Morris, K.N. and Wool, I.G. (1990). Determination by systematic deletion of amino acids
essential for catalysis by ricin A chain. Second International Symposium on
Immunotoxins: Lake Buena Vista, Florida.
CONFERENCE POSTER PRESENTATIONS
McCullough, A. and Morris, K. (October 26-29, 2013). Canines and Childhood Cancer:
Measuring the effects of animal-assisted therapy for pediatric oncology patients, their
parents and therapy dogs. American Academy of Pediatrics: Orlando, Florida.
Morris, K.N. and McCullough, A. (July 18-19, 2013). Canines and Childhood Cancer:
Measuring the effects of animal-assisted therapy for patients, families and therapy dogs.
International Society for Anthrozoology Conference: Chicago, Illinois.
Morris, K. and McCullough, A. (July 18-19, 2013). Canines and Childhood Cancer:
Measuring the effects of animal-assisted therapy for patients, families and therapy
dogs. International Society for Anthrozoology Conference: Chicago, Illinois.
Morris, K., Ruehrdanz, A., McCullough, A., and Jenkins, M. (June 13-14, 2013). Canines
and Childhood Cancer: Examining the effects of animal-assisted therapy for children
with acute lymphoblastic leukemia, their primary caregivers, and therapy dogs. American
College of Veterinary Internal Medicine Forum: Seattle, Washington.
PATENTS
Weil, M., Morris, K.N. and Malzbender, R. Targeting agents for enhanced low-energy
radiosurgery. United States Patent 8709380. Issued April 29, 2014. Assigned to Sirius
Medicine, LLC.
Weil, M. and Morris, K.N. Pharmaceutically enhanced low-energy radiosurgery. United
States Patent 7481758. Issued January 27, 2009. Assigned to Sirius Medicine, LLC.
Kevin Nolan Morris, Ph.D.
6
Chen, H., Gold, L., Jensen, K.B., Morris, K.N. and Stephens, A. Systematic evolution of
ligands by exponential enrichment: Tissue SELEX. United States Patent
WO1996034875. Issued December 30, 2008. Assigned to NeXstar Pharmaceuticals.
Cash, W., Morris, K., and Weil, M. X-ray concentrator for therapy. United States Patent
Publication Number US20030012336 A1. Issued January 16, 2003. Assigned to Sirius
Medicine, LLC.
Kevin Nolan Morris, Ph.D.
7